Another potent inducer of prostate cancer cell growth is JAK/STAT signaling axis, which additionally regulates resistance to ADT [75] as well as the immune escape of CRPC to natural killer (NK) cells in hypoxia [76], which could be exploited in immunotherapy against prostate cancer. Here, SOAT1 is linked to prostate carcinoma.